Vaccines Market Research Reports
Vaccine stands for a preparation of dead, attenuate or else modified viruses, bacteria and other microorganisms utilized as an inoculation to immunize against any disease by way of stimulating antibodies’ production. With constant technology upgrades and launches of new medicinal products, Vaccines proved to be the most sophisticated healthcare aid ever created in the pharma’s history.
The global Vaccine Industry is thriving mainly owing to the chronic availability of different diseases, both already-existing and cropping up on the horizon, which can be luckily prevented with Vaccines’ assistance. Pediatric Vaccines form the largest and the most hastily evolving segment as against adult Vaccines, with the trend predicted to stay unaltered in the impending period. The worldwide Vaccine Market is primarily in the paws of such behemoths as Merck & Company, Inc.; Novartis, Pfizer, Inc.; GlaxoSmithKline plc; and Sanofi Pasteur.
The research reports under this Catalogue provide in-depth assessments of the global Vaccine Industry, discussing pressing market issues and statistical figures. The research reports cover the sizing (value/volume) and short-to-long-run forecasts for the overall Vaccine Market and its major segments, and for numerous geographic markets. The listing of M&As among the Vaccine universe participants with new products’ reviews, alongside company profile information can be derived from the research reports too.
... provider GBI Research has released its latest research report, entitled “Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningococcal ... , France, Italy, Spain, and Japan. Market characterization of the Travel Vaccines market including market size, cost of vaccination. Key drivers and ...
May, 2013 116 pagesThis market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different American countries. The studies ... different types of products? Which products are growing fast? How the markets have been developing? How does the future look like? ...
May, 2013 190 pages... indicators This market study answers to questions such as: What is the size of the global vaccine market? How is the market divided into different types of products? Which products are growing fast? How the market has been developing? How does the future look like? What is the ...
May, 2013 19 pages... this market growth is the increase in demand for vaccination. The Strategic Overview of Global Preventable Vaccine market has also been witnessing the ... pose a challenge to the growth of this market. TechNavio's report, the Strategic Overview of Global Preventable Vaccine Market 2012-2016, has been prepared ...
Apr, 2013 111 pages... business intelligence provider, has released its latest research “Therapeutic Cancer Vaccines Market to 2019 - Pipeline Indicates Safer Treatments and Extended ... . A statistical analysis of clinical trial duration and size by phase and by vaccine type. An in depth forecast model for each indication for which ...
Mar, 2013 115 pages... intelligence provider has released its latest research “Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset ... ’ support, growing population in the APAC region and entry of novel vaccines and production technologies. GBI Research finds that the Philippines’ ...
Apr, 2013 137 pages... Novel Candidates in Late-Stage Development and Prevnar Approval for Use in Adults to Drive Growth Summary The leading business intelligence provider GBI ... understanding of key drivers and barriers of the global adult and adolescent vaccines market Develop key strategic initiatives by understanding the key ...
Apr, 2013 124 pages... Future Players SUMMARY GlobalData has released its pharma report, “PharmaPoint: Seasonal Influenza Vaccines - Current and Future Players”. The report is a vital ... information with in-depth analysis on the companies in the rapidly growing Seasonal Influenza Market. The report identifies and analyses the key ...
Nov, 2012 92 pages... India. The analysis of market drivers explains the reasons behind the growth of vaccine industry in India. The major factors driving growth of the Indian ... (PPP) and public and private sector spending. The report titled “Indian Vaccine Industry: Trends and Opportunities (2012-2017) offers in-depth study of ...
Dec, 2012 62 pages... the worlds leading healthcare companies during 2012 DESCRIPTION The Vaccines Partnering Yearbook 2013 report series provides comprehensive understanding and unprecedented ... , dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you ...
Jan, 2013 200 pages... Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Vaxigrip (Seasonal Influenza Vaccines) Forecast and Market Analysis”. ... description, safety and efficacy profiles as well as a SWOT analysis. Sales forecast for Vaxigrip for the top six countries from 2012 to 2022. ...
Nov, 2012 37 pages... Summary GlobalData has released its new Country report, “PharmaPoint: Seasonal Influenza Vaccines United States Drug Forecast and Market Analysis”. ... the majority stake of the market. However, with the entrance of vaccines with novel routes of administration, such as AstraZeneca’s intranasal FluMist and ...
Nov, 2012 112 pages... Summary GlobalData has released its new Country report, “PharmaPoint: Seasonal Influenza Vaccines United Kingdom Drug Forecast and Market Analysis”. ... the majority stake of the market. However, with the entrance of vaccines with novel routes of administration, such as AstraZeneca’s intranasal FluMist and ...
Nov, 2012 85 pages... Analysis Summary GlobalData has released its new Country report, “PharmaPoint: Seasonal Influenza Vaccines Spain Drug Forecast and Market Analysis”. ... the majority stake of the market. However, with the entrance of vaccines with novel routes of administration, such as AstraZeneca’s intranasal FluMist and ...
Nov, 2012 74 pages... Analysis Summary GlobalData has released its new Country report, “PharmaPoint: Seasonal Influenza Vaccines Japan Drug Forecast and Market Analysis”. ... the majority stake of the market. However, with the entrance of vaccines with novel routes of administration, such as AstraZeneca’s intranasal FluMist and ...
Nov, 2012 55 pages... Analysis Summary GlobalData has released its new Country report, “PharmaPoint: Seasonal Influenza Vaccines Italy Drug Forecast and Market Analysis”. ... the majority stake of the market. However, with the entrance of vaccines with novel routes of administration, such as AstraZeneca’s intranasal FluMist and ...
Nov, 2012 83 pages... Analysis Summary GlobalData has released its new Country report, “PharmaPoint: Seasonal Influenza Vaccines India Drug Forecast and Market Analysis”. ... the majority stake of the market. However, with the entrance of vaccines with novel routes of administration, such as AstraZeneca’s intranasal FluMist and ...
Nov, 2012 62 pages... Analysis Summary GlobalData has released its new Country report, “PharmaPoint: Seasonal Influenza Vaccines France Drug Forecast and Market Analysis”. ... the majority stake of the market. However, with the entrance of vaccines with novel routes of administration, such as AstraZeneca’s intranasal FluMist and ...
Nov, 2012 78 pages... Analysis Summary GlobalData has released its new Country report, “PharmaPoint: Seasonal Influenza Vaccines China Drug Forecast and Market Analysis”. ... the majority stake of the market. However, with the entrance of vaccines with novel routes of administration, such as AstraZeneca’s intranasal FluMist and ...
Nov, 2012 70 pages... Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Optaflu (Seasonal Influenza Vaccine) Forecast and Market Analysis”. ... Optaflu from its competitors. The viral subtypes present in the vaccine are cultivated in a Madin Darby Canine Kidney (MDCK) cell line that has ...
Nov, 2012 37 pages
